Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsThe pandemic elevated the priority placed on healthcare by governments and patients, and we saw a ~9% increase in spend during the pandemic on this $ 3 trillion+ industry in APAC. With COVID-19 now in the rear view mirror, the industry is expected to sustain this unprecedented change in spend — signaling the demand is real and the region is evolving. Despite inflationary pressures around the world, patient numbers have grown between 15% to 30%, depending on the disease, indicating there is a surge in demand for products and services across the Asian healthcare industry. However, supply is lagging — healthcare facilities are overcrowded, physician-population ratios are declining, medicine availability is low and funding increase is insufficient. We have seen this market dynamic before, and the longer this demand-supply mismatch plays out, the longer the window of opportunity for innovators and disruption to take a crack at ~$250bn of market creation needed in the near-term.
Authors:
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.